Fig. 2: A 44 year-old woman with TNBC undergoing NAST. | npj Breast Cancer

Fig. 2: A 44 year-old woman with TNBC undergoing NAST.

From: Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancer

Fig. 2: A 44 year-old woman with TNBC undergoing NAST.

MRI at baseline (A), after two cycles (B), and four cycles (C) of AC shows an oval, heterogeneously enhancing mass with associated clip marker (arrows). MRI shows concentric shrinkage and tumor volume reduction of 83% after two cycles, and 96% after four cycles. Pathology after the completion of NAST confirmed pathologic complete response.

Back to article page